Search

everythinglearnresearchcommunity

for

Search:↓

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Testosterone helps human pancreatic cells increase insulin release.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Retinoic acid affects male and female muscle energy use and function differently.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Mice hair growth patterns get more complex with age and can change with events like pregnancy or injury.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Dieckol from Ecklonia cava may help hair growth and could be a potential hair loss treatment.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Licorice has many traditional health benefits, but more research is needed to fully support these claims.

Father's finasteride use may affect son's fertility and testicular function.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Treating melasma in men is difficult, especially for the deeper skin layers, and may need more than just topical treatments.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Androgen use may increase the risk of stroke, but more research is needed.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Cells with active Wnt signaling are less likely to turn into cancer when exposed to a cancer-causing gene.